Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

New Neuro One Topical Cream Promises Peripheral Neuropathy Relief

One west coast neuropathy patient and his doctor have developed an innovative new non-prescription remedy to help those like him living with diabetes.


News provided by

Neuropathy Research Inc.

Dec 07, 2021, 15:35 ET

Share this article

Share toX

Share this article

Share toX


SAUSALITO, Calif., Dec. 7, 2021 /PRNewswire-PRWeb/ -- California-based Neuropathy Research Inc. announced the release of its L-arginine-based topical cream designed to relieve the symptoms of peripheral neuropathy (PN). PN refers to pain, tingling, and numbness in the feet or hands suffered by as many as 30 million Americans, the majority of them diabetics. Causes of PN include diabetes, vitamin B-12 deficiency, excessive alcohol consumption, and age. There is no known cure, and the re-purposed anti-seizure medications commonly prescribed to treat the condition often don't work or cause unpleasant, sometimes intolerable, side effects.

All that was what company co-founder Tony Cook learned from his doctor, Arlene F. Hoffman, DPM, Ph.D., a veteran podiatrist and medical researcher in San Francisco. "She told me my peripheral neuropathy was idiopathic – meaning cause unknown," recalls Cook, "and the doctor dispensed a topical formulation that she said had helped the many PN patients in her care."

We’re introducing this to a wider audience because we are convinced from our own experience that the nourishing impact of L-arginine can support nerve health, improve sensation, and relieve the numbness, pain, and tingling of peripheral neuropathy.

Post this

It turns out that Dr. Hoffman had studied with a fellow scientist in her youth, Dr. Robert Furchgott, who was awarded a Nobel Prize in 1998 for the discovery of nitric oxide, a molecule essential for nerve function. It was later discovered that L-arginine, a naturally occurring amino acid, increased the production of nitric oxide. This led Dr. Hoffman to begin incorporating L-arginine into her topical treatments for PN.

It worked, explains Dr. Hoffman, because the L-arginine could reach the damaged nerves causing the symptoms, since these spidery or "small-fiber" peripheral nerves were close to the surface of the skin and could therefore be readily nourished. The treatments relieved Cook's symptoms, and he was impressed enough by the doctor's logic and scientific explanations that he co-founded a company with a partner to develop a topical cream based on Hoffman's insights. Explains Cook, a 79-year-old serial entrepreneur, "I wanted to pay it forward and use the formulation to help the many, many others with my condition the way it had helped me."

The product derived from that development effort is the newly launched Neuro One Nerve Support Cream for Peripheral Neuropathy, a non-prescription formulation containing natural ingredients and manufactured in a California-based cosmeceutical facility that is cGMP compliant, FDA registered, and has earned the USDA's National Organic Program certification. Every Neuro One ingredient is sourced with care, and the product contains nothing from China.

Unlike competitor foot creams that supposedly relieve PN, Neuro One is not a muscle rub. It has no menthol or CBD that simply masks symptoms instead of supporting essential nerve function. No fragrance or dyes are added, and it contains no capsaicin, which helps some people with neuropathy pain but can cause irritating burning sensations in others.

The product is dispensed in an airless pump bottle to keep bacteria from forming with exposure to the air and to maintain the purity of the natural ingredients. It contains a full 100 ml (3.4 fluid ounces). Apply the cream twice per day, being careful to cover the entire top and bottom of the foot, including all around the ankle. Dr. Hoffman says her patients usually experience relief within a few minutes to a few days; for some, relief can take up to a month.

Adds Cook, "We're introducing this to a wider audience because we are convinced from our own experience that the nourishing impact of L-arginine can support nerve health, improve sensation, and relieve the numbness, pain, and tingling of peripheral neuropathy." Neuro One is available on Amazon and can also be purchased online at NeuropathyResearch.com.

About Neuropathy Research Inc.:
Neuropathy Research Inc. is a health products and information company providing insights and self-care solutions for the relief of peripheral neuropathy. Our topical treatment, Neuro One Nerve Support Cream, is a natural formulation containing L-arginine designed to nourish nerves in the feet and hands and stimulate nerve health. For help, visit http://www.NeuropathyResearch.com.

Press Contact:
Tony Cook
[email protected]

Media Contact

Caroline Dranow, Mediaplanet, 6469221400, [email protected]

SOURCE Neuropathy Research Inc.

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.